Structural insight into the lead identification of a dual inhibitor of PDE1B and PDE10A: Integrating pharmacophore-based virtual screening, molecular docking, and structure-activity-relationship approaches. [PDF]
Soon CW, Gaurav A, Gautam V, Al-Nema M.
europepmc +1 more source
Discovery of Novel Allosteric SHP2 Inhibitor Using Pharmacophore-Based Virtual Screening, Molecular Docking, Molecular Dynamics Simulation, and Principal Component Analysis. [PDF]
Singh P, Kumar V, Lee KW, Hong JC.
europepmc +1 more source
Pharmacophore-Based Virtual Screening Toward the Discovery of Novel Anti-echinococcal Compounds. [PDF]
Liu C +5 more
europepmc +1 more source
Exploring a repurposed candidate with dual hIDO1/hTDO2 inhibitory potential for anticancer efficacy identified through pharmacophore-based virtual screening and in vitro evaluation. [PDF]
Aboomar NM +4 more
europepmc +1 more source
Discovery of HIV entry inhibitors via a hybrid CXCR4 and CCR5 receptor pharmacophore-based virtual screening approach. [PDF]
Mirza MU +9 more
europepmc +1 more source
Improvement of ligand-based virtual screening by introducing pharmacophore fingerprint
identifier:oai:t2r2.star.titech.ac.jp ...
openaire +1 more source
Pharmacophore Models and Pharmacophore-Based Virtual Screening: Concepts and Applications Exemplified on Hydroxysteroid Dehydrogenases [PDF]
Computational methods are well-established tools in the drug discovery process and can be employed for a variety of tasks. Common applications include lead identification and scaffold hopping, as well as lead optimization by structure-activity relationship analysis and selectivity profiling.
Muhammad Akram +2 more
exaly +9 more sources

